Evolus

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Evolus and other ETFs, options, and stocks.

About EOLS

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. 

CEO
David Moatazedi
CEODavid Moatazedi
Employees
334
Employees334
Headquarters
Newport Beach, California
HeadquartersNewport Beach, California
Founded
2012
Founded2012
Employees
334
Employees334

EOLS Key Statistics

Market cap
414.76M
Market cap414.76M
Price-Earnings ratio
-6.95
Price-Earnings ratio-6.95
Dividend yield
Dividend yield
Average volume
843.22K
Average volume843.22K
High today
$6.67
High today$6.67
Low today
$5.47
Low today$5.47
Open price
$5.47
Open price$5.47
Volume
2.49M
Volume2.49M
52 Week high
$12.24
52 Week high$12.24
52 Week low
$3.86
52 Week low$3.86

Stock Snapshot

The current Evolus(EOLS) stock price is $6.38, with a market capitalization of 414.76M. The stock trades at a price-to-earnings (P/E) ratio of -6.95.

As of 2026-05-05, Evolus(EOLS) stock has fluctuated between $5.47 and $6.67. The current price stands at $6.38, placing the stock +16.5% above today's low and -4.4% off the high.

Evolus(EOLS) shares are trading with a volume of 2.49M, against a daily average of 843.22K.

During the past year, Evolus(EOLS) stock moved between $3.86 at its lowest and $12.24 at its peak.

During the past year, Evolus(EOLS) stock moved between $3.86 at its lowest and $12.24 at its peak.

EOLS News

TipRanks 17h
Evolus Earnings Call Highlights Profitable Growth Path

Evolus, Inc. ((EOLS)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerf...

The Motley Fool 20h
Evolus Q1 2026 Earnings Transcript

Image source: The Motley Fool. Monday, May 4, 2026 at 4:30 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer — David Moatazedi Chief Financial Of...

Evolus Q1 2026 Earnings Transcript
TipRanks 21h
Evolus Ends ATM Facility After Strong Q1 Momentum

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

More EOLS News

TipRanks 21h
Evolus reports Q1 EPS (16c), consensus (12c)

Reports Q1 revenue $73.1M, consensus $72.17M. “We started 2026 with a second consecutive quarter of positive Adjusted EBITDA, delivering profitability in what i...

People also own

Based on the portfolios of people who own EOLS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.